| Literature DB >> 28282803 |
Elif Ugurel, Zeynep Kucuksumer, Buse Eglenen, Ozlem Yalcin.
Abstract
BACKGROUND: Erythrocytes undergo irreversible morphological and biochemical changes during storage. Reduced levels of deformability have been reported for stored erythrocytes. Erythrocyte deformability is essential for healthy microcirculation.Entities:
Keywords: CPDA-1; Erythrocyte deformability; blood storage; metabolic depletion; shear stress
Mesh:
Year: 2017 PMID: 28282803 PMCID: PMC5523916 DOI: 10.3233/CH-160219
Source DB: PubMed Journal: Clin Hemorheol Microcirc ISSN: 1386-0291 Impact factor: 2.375
Deformability measurements (EI = Mean±SD) before and after continuous shear stress (SS) in the fresh blood (1st day) and, on the 7th and 35th days of storage with CPDA-1 (n = 11 in each group)
| Shear | Before SS | After 5 Pa SS | After 10 Pa SS | ||||||
| Stress (Pa) | EI | EI | EI | ||||||
| 1st Day | 7th Day | 35th Day | 1st Day | 7th Day | 35th Day | 1st Day | 7th Day | 35th Day | |
| 0.3 | 0.046±0.02 | 0.054±0.01 | 0.074±0.01 | 0.071±0.02* | 0.093±0.02*, | 0.096±0.02*, | 0.073±0.02* | 0.094±0.02*, | 0.095±0.01*, |
| 0.53 | 0.107±0.02 | 0.118±0.02 | 0.119±0.02 | 0.132±0.03* | 0.144±0.02*, | 0.133±0.02* | 0.128±0.02* | 0.150±0.02*, | 0.131±0.01*, |
| 0.94 | 0.184±0.03 | 0.197±0.02 | 0.186±0.02 | 0.206±0.03* | 0.222±0.03*, | 0.200±0.03*,Σ | 0.207±0.03* | 0.228±0.02*, | 0.200±0.02*, |
| 1.65 | 0.271±0.03 | 0.290±0.02 | 0.267±0.03 | 0.291±0.03* | 0.315±0.03*, | 0.286±0.03*,Σ | 0.290±0.03* | 0.316±0.02*, | 0.284±0.02*, |
| 2.91 | 0.373±0.03 | 0.388±0.02 | 0.361±0.03 | 0.392±0.02* | 0.407±0.02*, | 0.377±0.03*, | 0.388±0.03* | 0.408±0.02*, | 0.375±0.02*, |
| 5.15 | 0.462±0.02 | 0.466±0.02 | 0.437±0.02 | 0.473±0.02 | 0.479±0.02* | 0.445±0.02 | 0.472±0.02 | 0.482±0.01* | 0.448±0.02 |
| 9.09 | 0.527±0.02 | 0.523±0.02 | 0.487±0.02 | 0.533±0.01 | 0.532±0.01 | 0.495±0.02 | 0.534±0.01 | 0.538±0.01* | 0.498±0.02 |
| 16.04 | 0.569±0.02 | 0.561±0.03 | 0.523±0.02 | 0.574±0.01 | 0.571±0.01 | 0.533±0.02 | 0.576±0.01 | 0.572±0.01 | 0.534±0.02 |
| 28.32 | 0.594±0.02 | 0.584±0.04 | 0.545±0.02 | 0.599±0.01 | 0.595±0.01 | 0.556±0.02 | 0.601±0.01 | 0.599±0.01* | 0.556±0.02 |
| 50.0 | 0.609±0.01 | 0.599±0.04 | 0.558±0.02 | 0.614±0.01 | 0.611±0.02 | 0.569±0.02 | 0.617±0.01 | 0.615±0.01* | 0.570±0.02 |
*Significance between before and after SS in each group (p≤0.05). Significance of control group with 7th and 35th day groups before SS (p≤0.05). Significance of control group with 7th and 35th day groups after 5 Pa SS (p≤0.05). Significance of control group with 7th and 35th day groups after 10 Pa SS (p≤0.05). Significance between 7th and 35th day groups before SS (p≤0.05). ΣSignificance between 7th and 35th day groups after 5 Pa SS (p≤0.05). Significance between 7th and 35th day groups after 10 Pa SS (p≤0.05).
Fig.1The levels of EImax, SS1/2 and SS1/2/EImax values in all studied samples (n = 11 in each group) before and after continuous SS. (A) SS1/2 levels in each group before and after continuous shear stress (SS). (B) EImax levels in each group before and after continuous shear stress (SS). (C) SS1/2/EImax levels in each group before and after continuous shear stress (SS). Significance between before and after SS in each group: *p≤0.05, significance of control group with 7th and 35th day groups before SS: δp≤0.05, significance of control group with 7th and 35th day groups after 5 Pa SS: ɛp≤0.05, significance of control group with 7th and 35th day groups after 10 Pa SS: p≤0.05, significance between 7th and 35th day groups before SS: p≤0.05, significance between 7th and 35th day groups after 5 Pa SS: p≤0.05, significance between 7th and 35th day groups after 10 Pa SS: p≤ 0.05.
Fig.2The change in EI with time in all studied samples (n = 11 in each group) at 5 and 10 Pa SS.
Deformability measurements (EI = Mean±SD) before and after continuous shear stress (SS) in the fresh blood (1st day) and metabolically depleted blood samples (after 48 hours) (n = 10 in each group)
| Shear Stress (Pa) | Control (Before SS) | After 5 Pa SS | After 10 Pa SS | |||
| EI | EI | EI | ||||
| 1st day | After 48 h | 1st day | After 48 h | 1st day | After 48 h | |
| 0.3 | 0.033±0.03 | 0.059±0.01 | 0.070±0.03* | 0.085±0.02*, | 0.069±0.02 | 0.08±0.02 |
| 0.53 | 0.033±0.02 | 0.114±0.02 | 0.129±0.03* | 0.142±0.02*, | 0.125±0.03 | 0.139±0.03 |
| 0.94 | 0.164±0.03 | 0.191±0.02 | 0.199±0.03* | 0.216±0.03*, | 0.199±0.03 | 0.215±0.03 |
| 1.65 | 0.252±0.03 | 0.294±0.02 | 0.288±0.03* | 0.320±0.02*, | 0.288±0.02 | 0.317±0.02 |
| 2.91 | 0.347±0.03 | 0.393±0.02 | 0.376±0.03* | 0.411±0.02*, | 0.378±0.02 | 0.410±0.02 |
| 5.15 | 0.431±0.02 | 0.468±0.01 | 0.452±0.02* | 0.477±0.01*, | 0.456±0.02 | 0.479±0.01 |
| 9.09 | 0.499±0.02 | 0.520±0.01 | 0.511±0.02* | 0.525±0.01 | 0.516±0.02 | 0.528±0.01 |
| 16.04 | 0.548±0.02 | 0.556±0.01 | 0.555±0.02 | 0.562±0.01 | 0.560±0.01 | 0.563±0.01 |
| 28.32 | 0.585±0.02 | 0.582±0.01 | 0.590±0.02 | 0.586±0.01 | 0.594±0.01 | 0.587±0.01 |
| 50.0 | 0.612±0.01 | 0.599±0.02 | 0.615±0.01 | 0.603±0.01 | 0.618±0.01 | 0.603±0.02 |
*Significant difference between before and after the application of shear stress (SS) of 5 Pa (p < 0.05). Significant difference between before and after 10 Pa (p < 0.05). Significant difference between 1st day and after 48 h (p < 0.05).
Fig.3The levels of SS1/2, EImax and SS1/2/EImax values before (control) and after continuous SS. Fresh blood samples (1st day, n = 10) are shown with white bars, metabolically depleted blood samples (after 48 hours, n = 10) are shown with black bars. (A) SS1/2 levels in each group before and after continuous SS. (B) EImax levels in each group before and after continuous SS. (C) SS1/2/EImax levels in each group before and after continuous SS. Significance between the 1st day and after 48 hours of incubation: *p≤0.05, significance of control with 5 and 10 Pa SS on the 1st day and after 48 hours of incubation:γ p≤0.05, significance between 5 and 10 Pa SS on the 1st day: p≤0.05.
Fig.4The change in EI with time on the 1st day and after 48 hours (n = 10 in each group) at 5 and 10 Pa SS.